CT-Guided Adaptive Radiation Therapy Combine With Anti-PD-1 Antibody Adjuvant Immunotherapy for Thoracic Cancer Patients
Status:
Recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
This phase II study is to evaluate the safety and efficacy of CT-based adaptive radiation
therapy followed by adjuvant anti-PD-1 antibody immunotherapy in treating patients with
different types and stages of thoracic malignancies. (CARTAI)